Sign in

What researchers published on Psoriatic arthritis

768 papers, newest first.

Showing 60 of 768

  • ReviewHarmonising difficult-to-manage and complex-to-manage psoriatic arthritis: from divergent prevalence estimates to reproducible, mechanism-aware phenotypes.The Lancet. Rheumatology
  • Measuring treatment response in psoriatic arthritis: comparison between PSoriatic Arthritis Response Criteria and Disease Activity Score.Rheumatology advances in practice
  • ReviewEfficacy and safety of deucravacitinib versus placebo in active psoriatic arthritis: a systematic review and meta-analysis.Autoimmunity reviews
  • Durable and Additive Disease Control at 52 Weeks With Ixekizumab Plus Tirzepatide Versus Ixekizumab Alone in Adults With Psoriatic Arthritis and Obesity or Overweight: Additional Results From a Randomized Clinical Trial.Arthritis & rheumatology (Hoboken, N.J.)
  • Two-Year Treatment Persistence and Effectiveness of Ixekizumab in Psoriatic Arthritis in Italian Clinical Practice: Results from the ROUTE-IXE Study.Rheumatology and therapy
  • Observational studyUnderstanding barriers: patient experience with immune-mediated rheumatic diseases in Brazilian public health.Advances in rheumatology (London, England)
  • ReviewMultidomain efficacy and safety of IL-17A and IL-17A/F inhibitors versus adalimumab in biologic-naïve psoriatic arthritis: A systematic review and Meta-analysis of comparative trials.Autoimmunity reviews
  • Foot and ankle involvement is common across the spondyloarthritis spectrum with distinct anatomical and clinical patterns: a post hoc cross-sectional analysis of the ASAS-PerSpA study.Rheumatology international
  • Extracapsular and joint-dominant hand and wrist MRI patterns in psoriatic and rheumatoid arthritis: an exploratory case-control study.Frontiers in immunology
  • Impact of radiographic damage on health-related outcomes across rheumatoid arthritis, psoriatic arthritis, and hand osteoarthritis: a comparative analysis of disease burden.Clinical rheumatology
  • Implementing Psoriatic Arthritis Screening and Dietary Interventions in Dermatology Practice: A Prospective Clinical Study.Journal of drugs in dermatology : JDD
  • Progression to Psoriatic Arthritis Among Psoriasis Patients Treated With JAK Inhibitors Compared With IL-17/23 Inhibitors.Journal of drugs in dermatology : JDD
  • Bimekizumab in Psoriatic Arthritis: 12-Month Retention, Multidomain Effectiveness, and Impact of Prior Interleukin-17 Inhibition in a Real-World Cohort.Joint bone spine
  • Risk of Major Cardiovascular Events in Patients with Psoriasis, Psoriatic Arthritis, and/or Other Forms of Spondyloarthritis: A Cohort of 72,291 Biologic New Users.BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy
  • Case reportAdult-onset chronic nonbacterial osteitis mimicking refractory axial psoriatic arthritis: successful treatment with combined IL-1/IL-17 inhibition: a case report and brief literature review.EULAR rheumatology open
  • Case reportPsoriatic Arthritis Without Cutaneous Manifestations: A Case of Diagnostic Delay, Pathologic Progression, and Psychological Burden.Cureus
  • Response to correspondence on 'Composite outcome measures that successfully differentiate active treatments from placebo in psoriatic arthritis trials' by Annfeldt et al.Annals of the rheumatic diseases
  • Difficult-to-manage psoriatic arthritis: Prevalence, phenotype, and clinical burden in real-world practice: insights from the SCQM registry.Seminars in arthritis and rheumatism
  • The development and validation of a new diagnostic sonographic enthesitis score for psoriatic arthritis: Diagnostic Ultrasound Enthesitis Tool (DUET).Arthritis & rheumatology (Hoboken, N.J.)
  • Incidence and prevalence of hidradenitis suppurativa across spondyloarthritis-related diseases: cohort study using electronic health records.Frontiers in immunology
  • Real‑world assessment of the effectiveness and response profiles of biologic DMARDs in psoriatic arthritis: findings from an emulated multicentre clinical trial.Annals of the rheumatic diseases
  • Simplified liquid chromatography-mass spectrometry quantification of adalimumab reveals peptide interference and modestly stronger exposure-response associations than ELISA.Analytica chimica acta
  • Predictors of b/tsDMARDs discontinuation and treatment response in psoriatic arthritis: results from the British Society for Rheumatology Psoriatic Arthritis Register (BSR-PsA).Rheumatology (Oxford, England)
  • Meta-analysisEpidemiology of Diabetes Mellitus in Patients With Psoriatic Arthritis: Current Evidence.Diabetes/metabolism research and reviews
  • Immunogenicity, Safety, and Clinical Outcomes Following Homologous and Heterologous SARS-CoV-2 Vaccination Regimens in Patients with Axial Spondyloarthritis and Psoriatic Arthritis: A Prospective Observational Study from the SAFER Cohort.Vaccines
  • Lightweight interpretable support vector machine SERS (LiSVM-SERS) learning framework for serological diagnosis of psoriatic arthritis and biomarker identification.Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy
  • Systematic reviewExercise, physical activity, and physical fitness in psoriasis and psoriatic arthritis: an umbrella review.Frontiers in immunology
  • IFN-γ, TNF-α, IL-10, IL-17 and IL-22 secretion capacities and activation profile of T cells in psoriatic arthritis patients under disease-modifying antirheumatic drug therapy.Frontiers in immunology
  • Cost-effectiveness of early versus delayed disease-modifying antirheumatic drugs for psoriatic arthritis.Lancet regional health. Americas
  • Prevalence of Psoriatic Arthritis among Patients with Psoriasis Using the Psoriatic Arthritis Screening Tool (PEST) Questionnaire in a Tertiary Government Institution.Acta medica Philippina
  • Does weather matter? Exploring associations between season and meteorological factors and psoriatic arthritis disease activity.RMD open
  • C reactive protein in psoriatic arthritis: an old biomarker or a jack of all trades?Rheumatology (Oxford, England)
  • Sustained Inhibition of Structural Damage Progression and Improvements in Disease Activity With Guselkumab in Biologic-Naïve Participants with Active and Erosive Psoriatic Arthritis: Results Through Week 48 of the Phase 3b Randomized, Double-Blind, Placebo-Controlled APEX Study.Arthritis & rheumatology (Hoboken, N.J.)
  • Single-cell analysis reveals CXCL16+ dendritic cells and clonally expanded GZMK+ CD4 T cells driving joint inflammation in psoriatic arthritis.Arthritis & rheumatology (Hoboken, N.J.)
  • Icotrokinra, a Targeted Oral Peptide, in Participants With Moderate-to-Severe Plaque Psoriasis and Self-Reported Psoriatic Arthritis: Results From a Pooled Analysis of the Phase 3 ICONIC-LEAD, ICONIC-ADVANCE 1, and ICONIC-ADVANCE 2 Trials.Journal of psoriasis and psoriatic arthritis
  • Sex-specific outcomes in methotrexate therapy among patients with psoriatic arthritis and psoriasis.EULAR rheumatology open
  • Observational studyDiagnostic performance of FIB-4 in detecting advanced liver fibrosis in patients with rheumatoid arthritis, psoriatic arthritis and psoriasis using methotrexate.Advances in rheumatology (London, England)
  • Sex of the Treating Rheumatologist and Disease Activity Outcomes in Psoriatic Arthritis.Mayo Clinic proceedings. Innovations, quality & outcomes
  • ReviewShort-term risk and long-term incidence rate of herpes zoster with upadacitinib in patients with atopic dermatitis and psoriatic arthritis: a systematic review and meta-analysis.Postepy dermatologii i alergologii
  • Observational studyChanges in biventricular myocardial function after six months of ixekizumab therapy in patients with psoriatic arthritis: a prospective speckle-tracking echocardiographic study.Rheumatology international
  • Depressive symptoms are associated with achieving remission in PsA patients - an analysis from the RABBIT-SpA register.BMC rheumatology
  • Cutaneous Deterioration Following Glucocorticoid Discontinuation in Psoriatic Arthritis: A Real-World Cohort Study.Journal of clinical medicine
  • IL-23 and monocyte interactions redirect human Th17.1 cells to an IL-17AhighIFN-γhigh potentially pathogenic profile.Frontiers in immunology
  • Case reportClinical case series: Emergence of psoriatic arthritis during biologic IL-23 pathway inhibition therapy for psoriasis.Frontiers in medicine
  • T cells form distinct spatially restricted immune responses in synovium of patients with psoriasis arthritis and rheumatoid arthritis.Frontiers in immunology
  • A Multi-Axis Plantar Load Measurement Platform for the Assessment of Foot Disorders: Comparison of Patients With Psoriatic Arthritis to a Healthy Control Cohort.Journal of foot and ankle research
  • Temporomandibular disorders in women with psoriatic arthritis by history of psoriasis: a cross-sectional study.Rheumatology international
  • Clinical and sonographic enthesitis in psoriatic arthritis patients and its relation to serum calprotectin level.Clinical rheumatology
  • TYK2-Wnt5a Crosstalk in Psoriatic Arthritis: A Hypothesized Immunopharmacological Axis for Inflammation and Structural Remodelling.Current drug targets
  • Beyond disease activity: patient-reported impact of disease states in psoriatic arthritis using PsAID-12 time-independent clustering.RMD open
  • Bimekizumab efficacy across GRAPPA domains to 3 years in patients with psoriatic arthritis: a post hoc analysis of two phase 3 studies.Rheumatology (Oxford, England)
  • Distinct clinical profiles of methotrexate intolerance and hepatotoxicity in psoriatic arthritis.ARP rheumatology
  • ReviewFunctional characterization of genetic variants associated with response to tumor necrosis factor inhibitors in psoriatic arthritis patients.Autoimmunity reviews
  • ReviewFrom drug mechanism-based to driver-guided therapy: targeting disease drivers in psoriatic arthritis.EULAR rheumatology open
  • Effect of abatacept on bone in patients with psoriatic arthritis-results from a prospective interventional high-resolution imaging study (ABEPSA).EULAR rheumatology open
  • Does articular and entheseal structural damage drive pain and patient-driven reported outcomes in patients with difficult-to-treat psoriatic arthritis? Results from a cross-sectional study.EULAR rheumatology open
  • Comparative enthesitis burden in psoriatic arthritis vs axial spondyloarthritis: a cross-sectional analysis of the Swiss Clinical Quality Management in Rheumatic Diseases (SCQM) registry.EULAR rheumatology open
  • Effectiveness of interleukin (IL)-23 and IL-12/23 inhibitors and factors associated with response in psoriatic arthritis with axial involvement: the APxis-IL12-23 study.Scandinavian journal of rheumatology
  • ReviewThe immunometabolic tipping point: forecasting the systemic shift from psoriasis to psoriatic arthritis.Frontiers in immunology
  • Clinic-Based Proportion of Psoriatic Arthritis and HLA-B27 Distribution in Korean Psoriasis Patients: A Retrospective Study.Annals of dermatology